Brief: Repare Therapeutics Q2 EPS USD -0.82
06/08/2024 21:05
Aug 06 (Reuters) - Repare Therapeutics Q2 operating expenses USD 38.392 million. * Q2 pretax profit USD -34.448 million * Q2 net income USD -34.774 million * Q2 income from operations USD -37.319 million
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln